semaglutide and prostate cancer Targeting obesity, metabolic syndrome, cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology GLP-1 Weight Loss Drugs May

The most common side effects reported were nausea and diarrhea: About half of adults who use GLP-1 agonists reported having experienced nausea, and about one-third of adults who use GLP-1 agonists reported having experienced diarrhea

Although evidence supporting the use of these medications for alcohol use disorder is growing, the field still needs to learn considerably more about them, particularly in identifying the underlying mechanisms

Here we show that oral intake of long-term oscillating glucose (LOsG) (4 times/day) for 38 days, which produces physiological glycemic variability in rats, can lead to -cells gaining metabolic memory in reactive oxygen species (ROS) stress

There are no fees unless we obtain compensation on your behalf